دوره 5، شماره 4 - ( volume 5, number 4 1392 )                   جلد 5 شماره 4 صفحات 144-150 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Najafi F, Rezvaninejad B S, Mohammadi S M. The Effects of Adding Spironolactone to ACEI or ARB on Proteinuria in Type 2 Diabetes. IJDO. 2013; 5 (4) :144-150
URL: http://ijdo.ssu.ac.ir/article-1-163-fa.html
The Effects of Adding Spironolactone to ACEI or ARB on Proteinuria in Type 2 Diabetes. دیابت و چاقی. 1392; 5 (4) :144-150

URL: http://ijdo.ssu.ac.ir/article-1-163-fa.html


چکیده:   (1172 مشاهده)
Abstract Objectives: Interruption of rennin-angiotensin-aldosterone system has become a leading therapeutic strategy in the treatment of diabetic nephropathy however, ACEIs and ARBs do not uniformly suppress the rennin-angiotensin-aldosterone system. Plasma aldosterone levels are elevated in a group of patients despite therapy and this phenomenon known as aldosterone escape or aldosterone break through. Materials and Methods: Forty-two type 2 diabetic patients with overt proteinuria were randomized into two groups and according to double-blind case-control study, one group was treated with spironolactone and others were treated with placebo for 4 months. Twenty-four hours urine protein, glomerular filtration rate (GFR) and blood pressure were measured at baseline and after 4 months of treatment. Serum potassium was checked at baseline and one month of treatment. Results: Urine protein decreased in case group by 26.5% at the end of 4 months, but increased in control group by 17.9% (P=0.003). GFR did not have any significant change in case group (P<0.354), but decreased in case group significantly (P<0.001). Conclusion: Our study showed that spironolactone 12.5 mg/day is safe (without hyperkalemia and gynecomastia) and effective to decrease proteinuria in diabetic patient with CKD1-2.
متن کامل [PDF 398 kb]   (426 دریافت)    
نوع مطالعه: پژوهشي | موضوع مقاله: تخصصي
دریافت: ۱۳۹۳/۷/۱۲ | پذیرش: ۱۳۹۳/۷/۱۲ | انتشار: ۱۳۹۳/۷/۱۲

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
کد امنیتی را در کادر بنویسید

کلیه حقوق این وب سایت متعلق به مجله ایرانی دیابت و چاقی می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2015 All Rights Reserved | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb